2002 PHD degree from Dept of Surgery, Ruijin Hospital; Post doctoral work at Mayo Clinic to start his dedication in sDNA testing.

2009 Obtained multiple intellectual property rights of stool DNA testing and became R&D director at Exact Sciences

2012 Developed Cologuard, the world’s first stool DNA test kit for colorectal cancer

2014 Cologuard clinical trial finished in April, FDA approval in August, included in health insurance reimbursement plan on the same day.

2015 Foundation of Creative Biosciences (Guangzhou) Co., Ltd

2018 November 20, Colosafe^® was approved by NMPA